Fund marks imply 5.1× the round — treated as a units change, held — shown at its early-stage round, Apr 2025 ($299.0M post-money).
- ·5 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Antares Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $30.0M | ▮ | ▮ |
| Mar 2025 | Early Stage VC | $40.0M | ▮ | ▮ |
Membership and data by Private Market View
Antares Therapeutics valuation
Antares Therapeutics is valued at approximately $299 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its early-stage round in Apr 2025, at a $299 million post-money valuation.
How much has Antares Therapeutics raised?
Antares Therapeutics has raised $177 million in total; 2 of its rounds are on record. The largest on record was a $40 million early-stage round in Mar 2025; the most recent was a $30 million early-stage round in May 2025.
Antares Therapeutics has filed 2 Form Ds with the SEC, most recently in May 2025 ($30 million sold to 35 investors).
Institutional holders and vehicles
1 SEC-registered fund reported 5 fair-value marks on Antares Therapeutics between May 2025 and May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Antares Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Antares Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Antares Therapeutics
- What is Antares Therapeutics worth?
- Antares Therapeutics is valued at $299.0M as of Oct 2026. Fund marks imply 5.1× the round — treated as a units change, held — shown at its early-stage round, Apr 2025 ($299.0M post-money).
- How much has Antares Therapeutics raised?
- Antares Therapeutics has raised $177.0M in total funding across 2 recorded rounds.
- When did Antares Therapeutics last raise?
- Antares Therapeutics last raised in May 2025 (Early Stage VC), raising $30.0M.